
CAS 1092578-46-5
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 produits concernés.
3-((3R,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
CAS :Formule :C16H20N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :312.3696Tofacitinib Impurity 42
CAS :Formule :C16H20N6OCouleur et forme :White To Off-White SolidMasse moléculaire :312.383-((3R,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
CAS :3-((3R,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrileDegré de pureté :98%Masse moléculaire :312.38g/mol(3R,4S)-Tofacitinib
CAS :Produit contrôlé<p>Applications (3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.<br>References Jiang, J., et. al.: J. med. Chem., 51, 8012 (2008)<br></p>Formule :C16H20N6OCouleur et forme :NeatMasse moléculaire :312.37(3R,4S)-Tofacitinib-d3
CAS :Produit contrôléFormule :C16D3H17N6OCouleur et forme :NeatMasse moléculaire :315.388(3R,4S)-Tofacitinib
CAS :<p>(3R,4S)-Tofacitinib is a synthetic compound that is being researched for the treatment of rheumatoid arthritis. It is a potent inhibitor of Janus Kinase 3 (JAK3) and Janus Kinase 1 (JAK1), which are important enzymes in cytokine signaling pathways that play a role in inflammation. (3R,4S)-Tofacitinib is metabolized to an impurity standard for the drug product. The metabolite has not been characterized and its concentration cannot be determined from analytical data.</p>Formule :C16H20N6ODegré de pureté :Min. 95%Masse moléculaire :312.37 g/mol(3R,4S)-Tofacitinib
CAS :(3R,4S)-Tofacitinib, the less active enantiomer of Tofacitinib, is a JAK3 inhibitor with an IC50 of 1 nM.Formule :C16H20N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :312.37






